Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Induced Pluripotent Stem Cell Meets Severe Combined Immunodeficiency Publisher



Kouchaki R1 ; Abdnikfarjam B2 ; Maali A3 ; Abroun S4 ; Foroughi F2 ; Ghaffari S5 ; Azad M1
Authors

Source: Cell Journal Published:2020


Abstract

Severe combined immunodeficiency (SCID) is classified as a primary immunodeficiency, which is characterized by impaired T-lymphocytes differentiation. IL2RG, IL7Ralpha, JAK3, ADA, RAG1/RAG2, and DCLE1C (Artemis) are the most defective genes in SCID. The most recent SCID therapies are based on gene therapy (GT) of hematopoietic stem cells (HSC), which are faced with many challenges. The new studies in the field of stem cells have made great progress in overcoming the challenges ahead. In 2006, Yamanaka et al. achieved reprogramming technology by introducing four transcription factors known as Yamanaka factors, which generate induced pluripotent stem cells (iPSC) from somatic cells. It is possible to apply iPSC-derived HSC for transplantation in patients with abnormality or loss of function in specific cells or damaged tissue, such as T-cells and NK-cells in the context of SCID. The iPSC-based HSC transplantation in SCID and other hereditary disorders needs gene correction before transplantation. Furthermore, iPSC technology has been introduced as a promising tool in cellular-molecular disease modeling and drug discovery. In this article, we review iPSC-based GT and modeling for SCID disease and novel approaches of iPSC application in SCID. © 2020 Royan Institute (ACECR). All rights reserved.
Related Docs
View other Related Docs
1. A Review on Leukemia and Ipsc Technology: Application in Novel Treatment and Future, Current Stem Cell Research and Therapy (2018)
2. Recent Advances in Gene Therapy and Modeling of Chronic Granulomatous Disease, Iranian Journal of Allergy# Asthma and Immunology (2019)
3. Dyskeratosis Congenita Future: Hematopoietic Stem Cell Transplantation or Gene Therapy?, Gene Reports (2025)
Experts (# of related papers)
View all Related Experts
Amir Ali Hamidieh (5)
Saeed Mohammadi (3)
Other Related Docs
4. Toward in Vitro Production of Platelet From Induced Pluripotent Stem Cells, Stem Cell Reviews and Reports (2022)
5. Promoter Methylation Status and Expression Levels of Rassf1a Gene in Different Phases of Acute Lymphoblastic Leukemia (All), International Journal of Hematology-Oncology and Stem Cell Research (2021)
6. Applied Stem Cell Research in Sickle Cell Disease, Comprehensive Hematology and Stem Cell Research: Volume 1-5 (2024)
7. Optimizing Peripheral Blood Stem Cells Transplantation Outcome Through Amend Relapse and Graft Failure: A Review of Current Literature, Experimental Hematology and Oncology (2017)
8. The Gene Expression Profile and Dna Methylation Pattern of Cdh1 and Dnmt1 Genes in Acute Promyelocytic Leukemia (Apl), Reports of Biochemistry and Molecular Biology (2020)
9. Peaceful Existence of Tumor Cells With Their Non-Malignant Neighbors: The Trade of Tumor Cells With Tumor Micro-Environment, Current Chemical Biology (2020)
10. Generation of Ccr5-Ablated Human Induced Pluripotent Stem Cells As a Therapeutic Approach for Immune-Mediated Diseases, Iranian Journal of Allergy# Asthma and Immunology (2019)
11. Disturbance in the Reconstitution of Distinct T-Cell Subsets and the Incidence of Gvhd Following Allo-Hsct in Pediatric Patients With Non-Malignant Hematological Disorders, Immunology Letters (2023)
12. T Helper 17 and Regulatory T-Cell Profile and Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients With Beta-Thalassemia, Transplant Immunology (2023)
13. Dual in Vivo T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation With Post-Transplant Cyclophosphamide and Anti-Thymocyte Globulin As a Third Salvage Transplant for Leukocyte Adhesion Deficiency With Graft Failure: A Case Report, Frontiers in Immunology (2024)
14. Lymphoid Lineage Differentiation Potential of Mouse Nuclear Transfer Embryonic Stem Cells, Biologicals (2015)
15. Special Report: Summary of the Eighth Workshop of the Worldwide Network for Blood and Marrow Transplantation on the Status and Issues Related to Hematopoietic Stem Cell Transplantation in Near-East Countries, Held in Pakistan From September 22 to 23, 2022, Hematology/oncology and stem cell therapy (2024)
16. Transplant and Kidney Repair, Stem Cells in Urology (2020)
17. Immunotherapy With Ex Vivo–Expanded Donor-Derived Nk Cells After Haploidentical Hsct in Pediatric Patients With Aml: A Phase I Pilot Study, Current Research in Translational Medicine (2025)
18. Hypoimmunogenic Pluripotent Stem Cells: A Game-Changer in Cell-Based Regenerative Medicine, International Immunopharmacology (2025)
19. The Influence of Kir Gene Polymorphisms and Kir-Ligand Binding on Outcomes in Hematologic Malignancies Following Haploidentical Stem Cell Transplantation: A Comprehensive Review, Current Cancer Drug Targets (2023)
20. Genetically-Modified Stem Cell in Regenerative Medicine and Cancer Therapy; a New Era, Current Gene Therapy (2022)